Cancer-related and treatment-related fatigue

被引:129
|
作者
Wang, Xin Shelley [1 ]
Woodruff, Jeanie F. [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Symptom Res, Houston, TX 77030 USA
基金
美国国家卫生研究院;
关键词
Cancer-related fatigue; Gynecological cancer; Patient-reported outcomes; Brief Fatigue Inventory; DOUBLE-BLIND TRIAL; QUALITY-OF-LIFE; PATIENTS RECEIVING CHEMOTHERAPY; RECURRENT EPITHELIAL OVARIAN; GYNECOLOGIC-ONCOLOGY-GROUP; CLINICAL-TRIALS; CHEMORADIATION THERAPY; MULTIPLE-SCLEROSIS; SYMPTOM BURDEN; FALLOPIAN-TUBE;
D O I
10.1016/j.ygyno.2014.10.013
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Fatigue is a distressing and persistent symptom for patients with gynecological cancer and for survivors. Debilitating cancer-related fatigue (CRF) is produced by both the disease and its treatment. Although awareness and study of CRF have grown in recent years, consistent assessment has not been a priority in routine medical practice. The pathophysiological mechanisms that induce CRF remain unclear, and effective pharmacological interventions have yet to be established. Based on the literature and our own research results, this review focuses on recent progress toward understanding the nature and causes of CRF and on several promising treatment modalities. Given the prevalence and severity of CRF in the gynecological cancer patient population, establishing standardized fatigue measurement and management methods in routine clinical oncology care is of utmost importance. Whether CRF has an underlying inflammatory cause is still hypothetical, however, and no mechanism-driven symptom intervention is currently in clinical use, even though the development of such interventions would provide patients with greater symptom control. Advancing translational and clinical fatigue research will require anatomical pathway studies and well-designed clinical investigations that focus on the development of mechanism-driven interventions based on physiological-behavioral fatigue research, implementation of guidelines for experimental designs, and discovery of biomarkers identifying individuals at high risk for CRF. Validated patient-reported outcomes measures are an essential component of such clinical studies. Because numerous subscales, unidimensional measures, and multidimensional measures exist, clinicians and researchers should consider individual circumstances, good clinical practice, and research goals as guides for choosing the most appropriate fatigue measurement tool. Additionally, education about CRF should be made available to all patients and their caregivers, as accurate and age-appropriate information about conditions like CRF can alleviate much of the stress and anxiety brought on by poor communication about this distressing condition. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:446 / 452
页数:7
相关论文
共 50 条
  • [41] Mechanisms of cancer-related fatigue
    Ryan, Julie L.
    Carroll, Jennifer K.
    Ryan, Elizabeth P.
    Mustian, Karen M.
    Fiscella, Kevin
    Morrow, Gary R.
    ONCOLOGIST, 2007, 12 : 22 - 34
  • [42] Cancer-related fatigue: Evolving concepts in evaluation and treatment
    Daniell, HW
    CANCER, 2004, 100 (11) : 2484 - 2484
  • [43] Efficacy and Safety of Modafinil in the Treatment of Cancer-Related Fatigue
    Cooper, Maryann R.
    Bird, Heather M.
    Steinberg, Michael
    ANNALS OF PHARMACOTHERAPY, 2009, 43 (04) : 721 - 725
  • [44] Is methylphenidate a useful treatment for cancer-related fatigue in children?
    Sharp, Victoria
    Finlay, Fiona
    Kevitiyagala, Diluki
    ARCHIVES OF DISEASE IN CHILDHOOD, 2013, 98 (01) : 80 - 82
  • [45] Cancer-Related Fatigue Epidemiology, Pathogenesis, Diagnosis, and Treatment
    Horneber, Markus
    Fischer, Irene
    Dimeo, Fernando
    Rueffer, Jens Ulrich
    Weis, Joachim
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2012, 109 (09): : 161 - U35
  • [46] Cancer-related fatigue: prevalence, assessment and treatment strategies
    Weis, Joachim
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2011, 11 (04) : 441 - 446
  • [47] Cancer-Related Fatigue: Causes and Current Treatment Options
    Melissa S.Y. Thong
    Cornelis J. F. van Noorden
    Karen Steindorf
    Volker Arndt
    Current Treatment Options in Oncology, 2020, 21
  • [48] Cancer-Related Fatigue: Causes and Current Treatment Options
    Thong, Melissa S. Y.
    van Noorden, Cornelis J. F.
    Steindorf, Karen
    Arndt, Volker
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2020, 21 (02)
  • [49] Cancer-related fatigue - Evolving concepts in evaluation and treatment
    Stasi, R
    Abriani, L
    Beccaglia, P
    Terzoli, E
    Amadori, S
    CANCER, 2003, 98 (09) : 1786 - 1801
  • [50] Cancer-related fatigue, quality of life, pharmacological treatment
    de Oliveira Campos, Maira Paschoin
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2012, 58 (02): : 131 - 131